Login / Signup

Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial.

Thomas RadtkeLisa KünziJulia KoppManuela RasiJulia BraunKyra D ZensBabette WinterAlexia AnagnostopoulosMilo Alan PuhanJan S Fehr
Published in: Trials (2024)
The study is registered at ClinicalTrials.gov. :NCT05890534, June 6, 2023.
Keyphrases
  • coronavirus disease
  • placebo controlled
  • sars cov
  • helicobacter pylori
  • double blind
  • helicobacter pylori infection
  • randomized controlled trial
  • clinical trial
  • phase ii
  • rectal cancer
  • phase ii study
  • locally advanced